These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 19878061)
1. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators. Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061 [TBL] [Abstract][Full Text] [Related]
4. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells. Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417 [TBL] [Abstract][Full Text] [Related]
5. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer. McCullough J; Haley R; Clay M; Hubel A; Lindgren B; Moroff G Transfusion; 2010 Apr; 50(4):808-19. PubMed ID: 19912586 [TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Lakota J; Fuchsberger P Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035 [No Abstract] [Full Text] [Related]
7. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood. Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670 [TBL] [Abstract][Full Text] [Related]
8. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454 [TBL] [Abstract][Full Text] [Related]
9. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079 [TBL] [Abstract][Full Text] [Related]
10. Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation. Abbruzzese L; Agostini F; Durante C; Toffola RT; Rupolo M; Rossi FM; Lleshi A; Zanolin S; Michieli M; Mazzucato M Vox Sang; 2013 Jul; 105(1):77-80. PubMed ID: 23384290 [TBL] [Abstract][Full Text] [Related]
12. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors. Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993 [TBL] [Abstract][Full Text] [Related]
13. [Morphologic and functional changes in thrombocytes after deep freezing with DMSO]. Böck M; Greither L; Heim MU Infusionsther Transfusionsmed; 1996 Apr; 23(2):76-9. PubMed ID: 8777365 [TBL] [Abstract][Full Text] [Related]
14. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677 [TBL] [Abstract][Full Text] [Related]
15. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment. Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272 [TBL] [Abstract][Full Text] [Related]
16. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735 [TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892 [TBL] [Abstract][Full Text] [Related]
18. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663 [TBL] [Abstract][Full Text] [Related]
19. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation. Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022 [TBL] [Abstract][Full Text] [Related]
20. Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide. Trummer T; Fox R; Koç JR; de Lima M; Otegbeye F Cytotherapy; 2020 Nov; 22(11):613-616. PubMed ID: 32600975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]